Navigation Links
Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
Date:5/15/2013

Pittsburgh, PA (PRWEB) May 15, 2013

Dr. Carr is internationally recognized as a leader in the development of novel proteomics methods and in their application in biology and medicine. Dr. Carr and his group collaborate with scientists throughout the greater Broad community (Broad Institute, Harvard, Harvard Medical School, and the 17 Harvard affiliated hospitals) to apply state-of-the art proteomics technology to address compelling questions in biology, chemistry and clinical medicine. He has over 200 publications on development and use of proteomics and biological mass spectrometry.

Carr’s lecture will address the new era of quantitative biology enabled by mass spectrometry based proteomic technologies that has arrived. The content, relative abundance, modification states and interaction partners of proteins in a dynamic and temporal manner on a near-global basis in organelles, whole cells and clinical samples, providing information of unprecedented detail can now be defined. At the Broad Institute, Carr and his team are employing these technologies in a wide array of studies including delineating the genetic underpinnings of mitochondrial disorders, connecting cancer genotype to molecular phenotype, unraveling the basis of the innate-immune response, identifying the mechanism of action of drug-like molecules and to discover and verify protein biomarkers of disease. A representative set of project vignettes will be presented to convey a sense of the breadth and depth of application of modern proteomics to biology and medicine.

When asked to comment on his work, Dr. Carr stated, "Significant improvements in mass spectrometry-based proteomic technologies over the past few years have greatly increased the value and necessity of analyzing proteins and their modifications in biology and medicine. The number of proteins observed in cells and tissues now begins to approximate the expected expressed proteome.” He added, “The ability to globally measure and quantify changes in key protein modifications such as phosphorylation, ubiquitinylation and acetylation provides a window into function and pathogenesis not accessible by genomic methods. These capabilities have facilitated adoption of proteomics as natural adjunct to genomic methods, yielding new knowledge and testable hypotheses in biology and medicine."

Visit pittcon.org for more information.

About Pittcon

Pittcon® is a registered trademark of The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania non-profit organization. Co-sponsored by the Spectroscopy Society of Pittsburgh and the Society for Analytical Chemists of Pittsburgh, Pittcon is the premier annual conference and exposition on laboratory science. Proceeds from Pittcon fund science education and outreach at all levels, kindergarten through adult. Pittcon donates more than a million dollars a year to provide financial and administrative support for various science outreach activities including science equipment grants, research grants, scholarships and internships for students, awards to teachers and professors, and grants to public science centers, libraries and museums. Visit Pittcon.org for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10727233.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
2. Avenida Suites Hires Director for Global Business Development
3. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
4. Darpa Director Shares Vision of a New Generation of Technology and Commercial Applications at SPIE Defense, Security, and Sensing
5. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
6. David Hooper Joins Evolution Marketing Research as Senior Director, Research
7. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
8. Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
9. Jerry Adams Joins VIC Technology Venture Development Board of Directors
10. Roberto DellOro Named Director of LMUs Bioethics Institute
11. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... 2017 /PRNewswire/ - Caprion Biosciences Inc., a world leading specialty CRO ... proteins predictive of early stage (latent) Mycobacterium tuberculosis (Mtb) infection ... monitoring (MRM-MS) platform. ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published ...
(Date:7/26/2017)... ... 2017 , ... Proscia Inc. , a software solutions provider for digital ... 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” will discuss how ... (AI, VR, Big Data) sectors are taking aim at cancer diagnosis and research. Proscia ...
(Date:7/26/2017)... ... July 25, 2017 , ... ... garner a better understanding of the considerations needed for designing ideal guide RNAs ... use of CRISPR-Cas9 to create targeted double-strand breaks in genomic DNA has greatly ...
(Date:7/26/2017)... ... 26, 2017 , ... Spectral imaging is a non-destructive technique ... This unique capability combines high resolution imaging with spectral analysis. The system ... for chemical analysis, quality control, and decision-making. , Snapshot spectral imaging is key ...
Breaking Biology Technology:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOG´s multi-biometrics system.   Continue ... ...
Breaking Biology News(10 mins):